132 related articles for article (PubMed ID: 11316375)
1. Naltrexone and relapse prevention treatment for cocaine-dependent patients.
Schmitz JM; Stotts AL; Rhoades HM; Grabowski J
Addict Behav; 2001; 26(2):167-80. PubMed ID: 11316375
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.
Schmitz JM; Stotts AL; Sayre SL; DeLaune KA; Grabowski J
Am J Addict; 2004; 13(4):333-41. PubMed ID: 15370932
[TBL] [Abstract][Full Text] [Related]
3. A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.
Schmitz JM; Green CE; Stotts AL; Lindsay JA; Rathnayaka NS; Grabowski J; Moeller FG
Drug Alcohol Depend; 2014 Mar; 136():100-7. PubMed ID: 24424425
[TBL] [Abstract][Full Text] [Related]
4. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.
Comer SD; Sullivan MA; Yu E; Rothenberg JL; Kleber HD; Kampman K; Dackis C; O'Brien CP
Arch Gen Psychiatry; 2006 Feb; 63(2):210-8. PubMed ID: 16461865
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone treatment of comorbid alcohol and cocaine use disorders.
Hersh D; Van Kirk JR; Kranzler HR
Psychopharmacology (Berl); 1998 Sep; 139(1-2):44-52. PubMed ID: 9768541
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.
Ling W; Hillhouse MP; Saxon AJ; Mooney LJ; Thomas CM; Ang A; Matthews AG; Hasson A; Annon J; Sparenborg S; Liu DS; McCormack J; Church S; Swafford W; Drexler K; Schuman C; Ross S; Wiest K; Korthuis PT; Lawson W; Brigham GS; Knox PC; Dawes M; Rotrosen J
Addiction; 2016 Aug; 111(8):1416-27. PubMed ID: 26948856
[TBL] [Abstract][Full Text] [Related]
7. A randomized placebo-controlled trial of gabapentin for cocaine dependence.
Bisaga A; Aharonovich E; Garawi F; Levin FR; Rubin E; Raby WN; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(3):267-74. PubMed ID: 16169160
[TBL] [Abstract][Full Text] [Related]
8. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
Monti PM; Rohsenow DJ; Swift RM; Gulliver SB; Colby SM; Mueller TI; Brown RA; Gordon A; Abrams DB; Niaura RS; Asher MK
Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone and coping skills therapy for alcohol dependence. A controlled study.
O'Malley SS; Jaffe AJ; Chang G; Schottenfeld RS; Meyer RE; Rounsaville B
Arch Gen Psychiatry; 1992 Nov; 49(11):881-7. PubMed ID: 1444726
[TBL] [Abstract][Full Text] [Related]
11. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
Jayaram-Lindström N; Hammarberg A; Beck O; Franck J
Am J Psychiatry; 2008 Nov; 165(11):1442-8. PubMed ID: 18765480
[TBL] [Abstract][Full Text] [Related]
13. A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence.
Pettinati HM; Kampman KM; Lynch KG; Dundon WD; Mahoney EM; Wierzbicki MR; O'Brien CP
Am J Addict; 2014; 23(6):591-7. PubMed ID: 25251201
[TBL] [Abstract][Full Text] [Related]
14. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
Pettinati HM; Kampman KM; Lynch KG; Suh JJ; Dackis CA; Oslin DW; O'Brien CP
J Subst Abuse Treat; 2008 Jun; 34(4):378-90. PubMed ID: 17664051
[TBL] [Abstract][Full Text] [Related]
15. Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study.
Grassi MC; Cioce AM; Giudici FD; Antonilli L; Nencini P
Pharmacol Res; 2007 Feb; 55(2):117-21. PubMed ID: 17174102
[TBL] [Abstract][Full Text] [Related]
16. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
Bisaga A; Mannelli P; Yu M; Nangia N; Graham CE; Tompkins DA; Kosten TR; Akerman SC; Silverman BL; Sullivan MA
Drug Alcohol Depend; 2018 Jun; 187():171-178. PubMed ID: 29674251
[TBL] [Abstract][Full Text] [Related]
17. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.
Schmitz JM; Mooney ME; Moeller FG; Stotts AL; Green C; Grabowski J
Drug Alcohol Depend; 2008 Apr; 94(1-3):142-50. PubMed ID: 18164144
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
McKay JR; Lynch KG; Shepard DS; Pettinati HM
Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
[TBL] [Abstract][Full Text] [Related]
19. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.
Kiefer F; Jahn H; Tarnaske T; Helwig H; Briken P; Holzbach R; Kämpf P; Stracke R; Baehr M; Naber D; Wiedemann K
Arch Gen Psychiatry; 2003 Jan; 60(1):92-9. PubMed ID: 12511176
[TBL] [Abstract][Full Text] [Related]
20. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.
Heinälä P; Alho H; Kiianmaa K; Lönnqvist J; Kuoppasalmi K; Sinclair JD
J Clin Psychopharmacol; 2001 Jun; 21(3):287-92. PubMed ID: 11386491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
